<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876054</url>
  </required_header>
  <id_info>
    <org_study_id>ABT-CIP-10279</org_study_id>
    <nct_id>NCT03876054</nct_id>
  </id_info>
  <brief_title>Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator</brief_title>
  <acronym>REALITY</acronym>
  <official_title>Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, post-market, non-randomized, single-arm, open-label study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The REALITY study is a post-market, prospective, non-randomized, single-arm, open-label
      study. It is intended to collect short- and long-term safety and effectiveness data on
      various populations implanted with Abbott's neurostimulation systems. This study has broad
      inclusion criteria and minimal exclusion criteria to ensure the results are representative of
      the real-world use of these devices. Enrollment caps will be implemented to ensure patients
      from approved indications are represented. Individuals who are scheduled to receive an
      implantable Abbott neurostimulation system are eligible for study consideration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2019</start_date>
  <completion_date type="Anticipated">April 2029</completion_date>
  <primary_completion_date type="Anticipated">April 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of device related adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>Collecting device related adverse events</description>
  </primary_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by using PROMIS-29</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>Patient Reported Outcomes Measurement Information System Adult Profile (PROMIS 29) - assess the overall quality of life</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by Numeric Rating Scale (NRS) for pain intensity,</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>Pain reported from 0 &quot;no pain&quot; - 10 &quot;worst imaginable pain&quot;</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by Pain Catastrophizing Scale (PCS)</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>A measure of &quot;an exaggerated negative mental set brought to bear during actual or anticipated painful experience.&quot;</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by Oswestry Disability Index (ODI) (optional)</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>A scale for measuring back-related physical function. Each section in the scale covers a different domain (pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life, and traveling). Each item is scored on a scale from 0-5 with the first item scored a &quot;0&quot; and representing no disability. The final item is scored a &quot;5&quot; and represents the maximum level of disability. The scores for each section are summed for a final score ranging from 0 to 50. For example: Example: 16 points scored on all 10 items (max 50) equals 32%. However, 16 points scored over 9 items (max 45) equals 35.6%. The final scores are categorized as follows: 0% to 20%: minimal disability, 21%-40%: moderate disability, 41%-60%: severe disability, 61%-80%: crippled, 81%-100%</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by pain condition-related medication usage</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>Information about medication usage</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical improvement from baseline to each follow up visit assessed by transcutaneous oxygen pressure measurement (TcPO2)</measure>
    <time_frame>Baseline, 6-month, 1-, 2-, 3-, 4-, 5-year</time_frame>
    <description>TcPO2 is used to measure oxygen level of the tissue below the skin</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Spinal cord stimulation (SCS)</arm_group_label>
    <description>Subjects using Abbott SCS systems</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal root ganglion stimulation (DRG)</arm_group_label>
    <description>Subjects using Abbott DRG system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal cord stimulation (SCS)</intervention_name>
    <description>Subjects will be implanted with market-released Abbott SCS systems</description>
    <arm_group_label>Spinal cord stimulation (SCS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dorsal root ganglion stimulation (DRG)</intervention_name>
    <description>Subjects will be implanted with market-released Abbott DRG system</description>
    <arm_group_label>Dorsal root ganglion stimulation (DRG)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This clinical investigation will enroll adult male and female individuals scheduled to have
        an Abbott neurostimulation system implanted. Subjects must meet all eligibility criteria
        and provide written informed consent prior to conducting any investigation-specific
        procedures not considered standard of care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must provide written informed consent prior to any clinical investigation
             related procedure.

          -  Subject is at least 18 years (or the minimum age required by local law to consent for
             participation in a clinical investigation) or older at the time of enrollment.

          -  Subject is scheduled to have an Abbott neurostimulation system implanted within 30
             days.

        Exclusion Criteria:

          -  Subject is enrolled, or intends to participate, in a competing clinical study, as
             determined by Abbott.

          -  Presence of other anatomic or comorbid conditions, or other medical, social, or
             psychological conditions that, in the investigator's opinion, could limit the
             subject's ability to participate in the clinical investigation or to comply with
             follow-up requirements.

          -  Subject is part of a vulnerable population including incapacitated individuals,
             individuals unable to read or write, individuals under the age of legal consent, and
             pregnant or breastfeeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Robyn Capobianco, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robyn Capobianco, PhD</last_name>
    <phone>+1 512 286 4274</phone>
    <email>robyn.capobianco@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicole Harbert</last_name>
    <phone>+1 972 526 4841</phone>
    <email>nicole.harbert@abbott.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Phoenician Centers for Research &amp; Innovation</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jesse Hatgis</last_name>
      <email>jesse.hatgis@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pain Institute of Southern Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Cornidez</last_name>
      <email>cornidezmd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jason Edward Pope, MD Inc</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jason Pope</last_name>
      <email>popeje@me.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Department of Anesthesia</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ajay Antony</last_name>
      <email>aantony@anest.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nura</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Schultz</last_name>
      <phone>763-537-6000</phone>
      <email>dschultz@nuraclinics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Pain Care</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fishell</last_name>
      <email>advancedpaincarenv@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nevada Advanced Pain Specialists</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Patterson</last_name>
      <email>patterson@nvadvancedpain.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ainsworth Institute of Pain Management</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corey Hunter</last_name>
      <email>chunter@ainpain.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Premier Pain Solutions</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javid Baksh</last_name>
      <email>jbaksh34@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Adena Bone and Joint Center</name>
      <address>
        <city>Chillicothe</city>
        <state>Ohio</state>
        <zip>45601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Malinowski</last_name>
      <email>Mark.malinowski@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pacific Sports and Spine</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Moore</last_name>
      <email>gmoore@neurospinellc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spinal Diagnostics</name>
      <address>
        <city>Tualatin</city>
        <state>Oregon</state>
        <zip>97062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Heros</last_name>
      <email>ROBERTH@SPINALDX.COM</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Interventional Pain and Spine</name>
      <address>
        <city>Exton</city>
        <state>Pennsylvania</state>
        <zip>19341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fishman</last_name>
      <email>mfishman@centerisp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Texas Pain Institute</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <zip>76542</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pankaj Mehta</last_name>
      <email>mehta.painrelief@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <state>South Holland</state>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>F.J.P.M Huygen</last_name>
      <email>f.huygen@erasmusmc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 12, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>spinal cord stimulation</keyword>
  <keyword>dorsal root ganglion stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

